KRTL Holding Group Announces Court Order Approving Further Cancellation and Correction of Legacy Shares and Establishing Corporate Baseline
Press Release
OTC Disclosure & News Service | 01/05/2026
KRTL Holding Group Inc. (OTC: KRTL) (the “Company” or “KRTL”), a diversified holding company with interests in biotech, agriculture, and emerging markets, announced that on January 2, 2026, the Third Judicial District Court of Salt Lake County, Utah, granted the Company’s Verified Motion to approve further cancellation and correction in relation to common stock listings. The Court’s order authorizes the cancellation and correction of 1,330,035 legacy shares of the Company’s common stock that, based on available records and the Company’s shareholder verification procedures, were determined to be unverified, unsubstantiated, or improperly issued. As of January 5, 2026, the Company’s transfer agent reports 98,016,072 shares of common stock outstanding; upon implementation of the court-authorized cancellations, the Company expects the reported outstanding share count to be reduced by 1,330,035 shares to 96,686,037 shares.
In its order, the Court addressed the Company’s efforts to restore the availability of accurate, reliable, and current public information. The Court found that the Company has completed PCAOB-audited financial statements as a good-faith effort to provide transparency and reliable information for shareholders and regulatory stakeholders. The Court further found that the Company has cancelled known unverified, unsubstantiated, or improperly issued shares, including 1,330,035 shares addressed by the motion, and that the Company’s current share structure accurately reflects validly issued and outstanding securities. The Court also found and ordered that the Company’s certified, current disclosures, including its PCAOB-audited financial statements and corrected share ledger filed as exhibits with the Court, shall serve as the Company’s official financial and corporate baseline going forward, including for purposes related to SEC Rule 15c2-11 review.
SEC Rule 15c2-11 generally governs the ability of broker-dealers to publish or submit quotations in the OTC market and requires, subject to exceptions, that certain current and publicly available issuer information be reviewed in connection with initiating or resuming quotations. The Company believes the Court’s baseline determination supports the reliability and consistency of the issuer information it makes publicly available in that context.
“This court order reinforces our commitment to transparency and responsible corporate governance,” said Cesar Herrera, Chief Executive Officer of KRTL. “It provides additional legal clarity to our share records and recognizes the Company’s current disclosures, including PCAOB-audited financial statements, as an official baseline for purposes related to broker-dealer information review under Rule 15c2-11. Our priority remains the long-term interests of our shareholders.”
This outcome builds on the Company’s previously disclosed shareholder verification initiative first announced on June 4, 2025. Investors can find prior updates in the Company’s public disclosures and press release archive on its website, and at the following link: KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative.
The Company believes that maintaining accurate corporate records and current public disclosures supports investor understanding and enhances the Company’s ability to engage with stakeholders, counterparties, and potential partners. Any statements regarding future quotation eligibility, market status, or exchange listing objectives are forward-looking and subject to risks and uncertainties.
About KRTL Holding Group Inc.
KRTL Holding Group Inc. (OTC: KRTL) operates through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp. The Company leverages strategic synergies across biotech, technology, and emerging markets to drive growth and deliver shareholder value.
For more information:
www.krtlholding.com | www.krtl-icc.com | www.krtlbiotech.com
Press Release
OTC Disclosure & News Service | 01/05/2026
KRTL Holding Group Inc. (OTC: KRTL) (the “Company” or “KRTL”), a diversified holding company with interests in biotech, agriculture, and emerging markets, announced that on January 2, 2026, the Third Judicial District Court of Salt Lake County, Utah, granted the Company’s Verified Motion to approve further cancellation and correction in relation to common stock listings. The Court’s order authorizes the cancellation and correction of 1,330,035 legacy shares of the Company’s common stock that, based on available records and the Company’s shareholder verification procedures, were determined to be unverified, unsubstantiated, or improperly issued. As of January 5, 2026, the Company’s transfer agent reports 98,016,072 shares of common stock outstanding; upon implementation of the court-authorized cancellations, the Company expects the reported outstanding share count to be reduced by 1,330,035 shares to 96,686,037 shares.
In its order, the Court addressed the Company’s efforts to restore the availability of accurate, reliable, and current public information. The Court found that the Company has completed PCAOB-audited financial statements as a good-faith effort to provide transparency and reliable information for shareholders and regulatory stakeholders. The Court further found that the Company has cancelled known unverified, unsubstantiated, or improperly issued shares, including 1,330,035 shares addressed by the motion, and that the Company’s current share structure accurately reflects validly issued and outstanding securities. The Court also found and ordered that the Company’s certified, current disclosures, including its PCAOB-audited financial statements and corrected share ledger filed as exhibits with the Court, shall serve as the Company’s official financial and corporate baseline going forward, including for purposes related to SEC Rule 15c2-11 review.
SEC Rule 15c2-11 generally governs the ability of broker-dealers to publish or submit quotations in the OTC market and requires, subject to exceptions, that certain current and publicly available issuer information be reviewed in connection with initiating or resuming quotations. The Company believes the Court’s baseline determination supports the reliability and consistency of the issuer information it makes publicly available in that context.
“This court order reinforces our commitment to transparency and responsible corporate governance,” said Cesar Herrera, Chief Executive Officer of KRTL. “It provides additional legal clarity to our share records and recognizes the Company’s current disclosures, including PCAOB-audited financial statements, as an official baseline for purposes related to broker-dealer information review under Rule 15c2-11. Our priority remains the long-term interests of our shareholders.”
This outcome builds on the Company’s previously disclosed shareholder verification initiative first announced on June 4, 2025. Investors can find prior updates in the Company’s public disclosures and press release archive on its website, and at the following link: KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative.
The Company believes that maintaining accurate corporate records and current public disclosures supports investor understanding and enhances the Company’s ability to engage with stakeholders, counterparties, and potential partners. Any statements regarding future quotation eligibility, market status, or exchange listing objectives are forward-looking and subject to risks and uncertainties.
About KRTL Holding Group Inc.
KRTL Holding Group Inc. (OTC: KRTL) operates through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp. The Company leverages strategic synergies across biotech, technology, and emerging markets to drive growth and deliver shareholder value.
For more information:
www.krtlholding.com | www.krtl-icc.com | www.krtlbiotech.com
